US FDA Commissioner Robert Califf Says No Formulas For Trial Diversity
The FDA does not appear likely to provide a calculation for sponsors to show clinical trial diversity, but agency officials seem split on how tough to enforce the new regulations intended to ensure all groups are adequately represented.
